Recruiting

Observational Study

Sponsor:

UCLA

Code:

NCT00899405

Conditions

Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.

Conditions

Lung Cancer

Study ID

NCT00899405

Start date

May 19, 2004

Status verified date

Jun, 2026

Completion date

May, 2034

Anticipated

Primary completion date

May, 2034

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

DISEASE CHARACTERISTICS:

  • Histologically or cytologically confirmed lung cancer

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • May have received prior EGFR inhibitors

Study Design

Enrollment

800 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients with lung cancer

Collection of archival tumor specimen at the beginning of the study and collection of blood samples at the beginning of the study and then at regular intervals

Primary outcome measure

  • Mutational status of the EGFR pathway [ Time Frame: up to 1 year ]

Central Contacts and Locations

Central contacts

Office of Clinical Research

916-382-6970OCRReferral@health.ucdavis.edu

Locations

University of California Davis Cancer Center

Recruiting

Sacramento, California, United States, 95817

Contacts

Office of Clinical Research

916-382-6970OCRReferral@health.ucdavis.edu

More Information

Sponsor

University of California, Davis

Last update posted

Jun 25, 2026

Last verified

Jun, 2026

Keywords

  • lung cancer

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, Davis on 2026-06-25.